First-in-human
Renal cell carcinoma
magnetic resonance imaging
metabolism
Journal
BJR case reports
ISSN: 2055-7159
Titre abrégé: BJR Case Rep
Pays: England
ID NLM: 101684132
Informations de publication
Date de publication:
02 May 2019
02 May 2019
Historique:
entrez:
21
8
2019
pubmed:
21
8
2019
medline:
21
8
2019
Statut:
ppublish
Résumé
Intratumoral genetic heterogeneity and the role of metabolic reprogramming in renal cell carcinoma (RCC) have been extensively documented. However, the distribution of these metabolic changes within the tissue has not been explored. We report on the first-in-human
Identifiants
pubmed: 31428445
doi: 10.1259/bjrcr.20190003
pmc: PMC6699984
mid: EMS81999
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Medical Research Council
ID : MC_UU_12022/6
Pays : United Kingdom
Références
Science. 1956 Feb 24;123(3191):309-14
pubmed: 13298683
Acta Oncol. 2008;47(5):941-7
pubmed: 17906983
Cancer Res. 2008 Oct 15;68(20):8607-15
pubmed: 18922937
Biochim Biophys Acta. 2010 Jan;1805(1):105-17
pubmed: 19931353
NMR Biomed. 2011 Oct;24(8):927-32
pubmed: 21416540
N Engl J Med. 2012 Mar 8;366(10):883-892
pubmed: 22397650
Sci Transl Med. 2013 Aug 14;5(198):198ra108
pubmed: 23946197
Biochemistry. 2014 Dec 2;53(47):7333-57
pubmed: 25369537
Methods Enzymol. 2015;561:171-96
pubmed: 26358905
Oncogenesis. 2016 Jan 25;5:e190
pubmed: 26807645
Magn Reson Med. 2018 Feb;79(2):643-653
pubmed: 28394085
Eur Urol. 2017 Dec;72(6):1028-1029
pubmed: 28765011
Magn Reson Med. 2018 Sep;80(3):864-873
pubmed: 29322616
Cancer Res. 2018 Jul 15;78(14):3755-3760
pubmed: 29769199
Extreme Mech Lett. 2018 May;21:25-34
pubmed: 30135864
Cell Metab. 2018 Nov 6;28(5):793-800.e2
pubmed: 30146487
NMR Biomed. 2018 Nov;31(11):e4004
pubmed: 30198124
Neoplasia. 2019 Jan;21(1):1-16
pubmed: 30472500